Filing Details

Accession Number:
0000885590-14-000009
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-01-14 16:01:54
Reporting Period:
2014-01-13
Filing Date:
2014-01-14
Accepted Time:
2014-01-14 16:01:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
885590 Valeant Pharmaceuticals International Inc. VRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1343811 Ann Norma Provencio 2150 St. Elzear Blvd. West
Laval A8 H7L 4A8
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, No Par Value Disposition 2014-01-13 5,000 $133.00 152,206 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This number represents the weighted average sale price for all sales of common stock sold by the reporting officer pursuant to a 10b5-1 trading plan. Actual sale executions were in the range of $132.63 and $133.33. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each price.